Fischer Medical Ventures Limited (NSE:FISCHER)
India · Delayed Price · Currency is INR 97.20
-9.87 (-9.22%)
Nov 4, 2025, 1:07 PM IST
Fischer Medical Ventures Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 1,707 | 1,107 | 209.81 | 1.8 | - | 1.65 | Upgrade |
| 1,707 | 1,107 | 209.81 | 1.8 | - | 1.65 | Upgrade | |
Revenue Growth (YoY) | 141.85% | 427.61% | 11588.75% | - | - | -10.28% | Upgrade |
Cost of Revenue | 1,214 | 917.59 | 165.76 | - | - | 0.8 | Upgrade |
Gross Profit | 492.55 | 189.4 | 44.05 | 1.8 | - | 0.85 | Upgrade |
Selling, General & Admin | 107.06 | 47 | 5.11 | 0.63 | 0.9 | - | Upgrade |
Other Operating Expenses | 150.08 | 108.97 | 20.35 | 1.01 | 0.98 | 1.03 | Upgrade |
Operating Expenses | 280.64 | 172.29 | 27.27 | 1.64 | 1.89 | 1.03 | Upgrade |
Operating Income | 211.9 | 17.11 | 16.78 | 0.15 | -1.89 | -0.18 | Upgrade |
Interest Expense | -18.18 | -4.03 | -0.68 | -0.17 | -0.09 | -0.18 | Upgrade |
Interest & Investment Income | 9.27 | 9.27 | 4.95 | - | - | - | Upgrade |
Earnings From Equity Investments | -3.83 | -4.87 | - | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | 92.48 | 2.65 | 0.06 | -0 | - | - | Upgrade |
EBT Excluding Unusual Items | 291.66 | 20.14 | 21.11 | -0.01 | -1.97 | -0.36 | Upgrade |
Pretax Income | 293.74 | 22.23 | 21.11 | -0.01 | -1.97 | -0.36 | Upgrade |
Income Tax Expense | 94.38 | 10.15 | 2.73 | 0.35 | 0.35 | -1.76 | Upgrade |
Net Income | 199.36 | 12.08 | 18.38 | -0.37 | -2.33 | 1.41 | Upgrade |
Net Income to Common | 199.36 | 12.08 | 18.38 | -0.37 | -2.33 | 1.41 | Upgrade |
Net Income Growth | 905.89% | -34.28% | - | - | - | - | Upgrade |
Shares Outstanding (Basic) | 700 | 670 | 111 | 2 | 2 | 2 | Upgrade |
Shares Outstanding (Diluted) | 706 | 670 | 169 | 2 | 2 | 2 | Upgrade |
Shares Change (YoY) | 20.28% | 295.30% | 9752.91% | - | - | - | Upgrade |
EPS (Basic) | 0.28 | 0.02 | 0.17 | -0.21 | -1.35 | 0.82 | Upgrade |
EPS (Diluted) | 0.28 | 0.02 | 0.11 | -0.21 | -1.35 | 0.82 | Upgrade |
EPS Growth | 739.50% | -83.31% | - | - | - | - | Upgrade |
Free Cash Flow | -1,487 | -927.26 | -78.37 | -1.46 | -1.77 | -0.57 | Upgrade |
Free Cash Flow Per Share | -2.11 | -1.38 | -0.46 | -0.85 | -1.03 | -0.33 | Upgrade |
Dividend Per Share | - | 0.005 | - | - | - | - | Upgrade |
Gross Margin | 28.86% | 17.11% | 20.99% | 100.00% | - | 51.76% | Upgrade |
Operating Margin | 12.42% | 1.55% | 8.00% | 8.52% | - | -10.67% | Upgrade |
Profit Margin | 11.68% | 1.09% | 8.76% | -20.33% | - | 85.21% | Upgrade |
Free Cash Flow Margin | -87.15% | -83.76% | -37.35% | -81.28% | - | -34.73% | Upgrade |
EBITDA | 228.2 | 23.69 | 17.68 | - | - | - | Upgrade |
EBITDA Margin | 13.37% | 2.14% | 8.43% | - | - | - | Upgrade |
D&A For EBITDA | 16.3 | 6.58 | 0.91 | - | - | - | Upgrade |
EBIT | 211.9 | 17.11 | 16.78 | 0.15 | -1.89 | -0.18 | Upgrade |
EBIT Margin | 12.42% | 1.55% | 8.00% | 8.52% | - | -10.67% | Upgrade |
Effective Tax Rate | 32.13% | 45.66% | 12.95% | - | - | - | Upgrade |
Revenue as Reported | 1,811 | 1,122 | 214.83 | 1.8 | - | 1.65 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.